Issue Title
Vol 16, No 3 (2014) Avastin in clinical chemotherapy of malignant tumors
Abstract
Gorbunova V.A.
Vol 21, No 1 (2019) HPV-associated lesions in the Russian Federation: assessment of the problem
Abstract PDF
(Rus)
Briko N.I., Lopukhov P.D., Kaprin A.D., Novikova E.G., Trushina O.I., Khaldin A.A., Isaeva D.R., Skvortsova A.I.
Vol 21, No 4 (2019) The role of a multidisciplinary approach in the treatment of hepatocellular carcinoma
Abstract PDF
(Rus)
Kit O.I., Vladimirova L.I., Storozhakova A.E., Snezhko T.A., Kalabanova E.A., Samaneva N.I., Svetitskaia I.V., Kabanov S.N.
Vol 22, No 1 (2020) Modern view on the issues of diagnosis and verification of axillary lymph nodes involvement in early breast cancer
Abstract PDF
(Rus)
Kolyadina I.V., Danzanova T.Y., Khokhlova S.V., Trofimova O.P., Kovaleva E.V., Rodionov V.V., Poddubnaya I.V.
Vol 22, No 1 (2020) The efficacy of the combination of eribulin and trastuzumab in advanced HER2-positive breast cancer: the results of Russian observational study
Abstract PDF
(Rus)
Kovalenko E.I., Artamonova E.V., Karabina E.V., Andreiashkina I.I., Prokof’eva E.A., Popova N.O., Gaisina E.A., Evstigneeva I.V., Shaidorov M.V., Zhiliaeva L.A., Ponomarenko D.M., Khasanova A.I., Mukhametshina G.Z., Koziakov A.E., Vorotilina L.V., Povyshev A.I., Simolina E.I., Marfutov V.V., Kozlov D.V., Suslova I.R., Shikina V.E., Karandeeva T.V., Shepel’ A.O., Kramskaia L.V., Oskirko D.A., Frolova O.S.
Vol 17, No 4 (2015) The ability to combine autodermoplasty in the treatment of patients with malignant tumors of the skin extremities (clinical observation)
Abstract
Vaschenko L.N., Dashkova I.R., Kechedzhieva E.E., Babieva S.M.
Vol 19, No 1 (2017) The role of bevacizumab in the treatment of patients with ovarian and cervical cancer
Abstract PDF
(Rus)
Khokhlova S.V.
Vol 21, No 1 (2019) The potential use of oncolytic viruses in breast cancer: historical aspects and future prospects (literature review)
Abstract PDF
(Rus)
Morozov D.A., Kolyadina I.V., Poddubnaya I.V., Chumakov P.M., Ilinskaya G.V., Bokhian V.Y., Sopova M.I.
Vol 11, No 3 (2009) Mesto tsetuksimaba v terapii metastaticheskogo raka tolstoy kishki
Abstract
Artamonova E.V.
Vol 21, No 3 (2019) Osimertinib for the first-line treatment of EGFR-positive non-small cell lung cancer
Abstract
Reutova E.V., Laktionov K.P., Iudin D.I., Neliubina L.A., Gorokhova G.K., Egorova A.V.
Vol 16, No 1 (2014) Clinical cases of treatment of hepatocellular carcinoma
Abstract
Lazarev S.A., Mamontov K.G., Manihas G.M., Antimonik N.Y.
Vol 17, No 1 (2015) A population-based portrait of breast cancer in russia: a cancer register-based analysis in russian
Abstract
Poddubnaya I.V., Kolyadina I.V., Kalashnikov N.D., Borisov D.A., Makarova M.V.
Vol 11, No 2 (2009) Neksavar® (sorafenib)v lechenii rasprostranennogo pochechno-kletochnogo raka
Abstract
Podregul'skiy K.E.
Vol 21, No 3 (2019) Modern ultrasound technologies in monitoring the effectiveness of chemotherapy for cervical cancer
Abstract
Musaeva Z.R., Chekalova M.A., Mesheryakov A.A.
Vol 17, No 3 (2015) Adenosquamous carcinoma of the colon: case report
Abstract
Nefedova N.A., Kharlova O.A., Malkov P.G., Kharlov N.S., Danilova N.V.
Vol 11, No 2 (2009) Lechenie metastazov kolorektal'nogo raka v pecheni
Abstract
Patyutko Y.I., Sagaydak I.V., Pylev A.L., Podluzhnyy A.N., Chuchuev E.S., Shishkina N.A.
Vol 10, No 4 (2008) Tsetuksimab pri lechenii metastaticheskogo kolorektal'nogo raka
Abstract
Sekacheva M.I., Skipenko O.G.
Vol 11, No 4 (2009) Denosumab (AMG-162) v profilaktike osteoporoza, vyzvannogo priemom ingibitorov aromatazy u bol'nykh rakom molochnoy zhelezy v ad\"yuvantnoy terapii i u bol'nykh rakom predstatel'noy zhelezy pri polnoy androgennoy blokade
Abstract
Lichinitser M.R., Semenov N.N.
Vol 18, No 2 (2016) Passive smoking prevalence among patients of krasnoyarsk regional oncologic dispensary
Abstract PDF
(Rus)
Kutumova O.Y., Kononova L.I., Dobretsova E.A., Shulmin A.B., Korotkova K.M., Rossiyeva T.V.
Vol 19, No 2 (2017) PARP inhibitors in female reproductive system cancers
Abstract PDF
(Rus)
Pokataev I.A., Tyulyandin S.A.
Vol 17, No 1 (2015) The role of targeted therapy in the treatment of advanced hepatocellular carcinoma
Abstract
Shakhnovich E.B., Kerbikov O.B., Kulaga E.A.
Vol 18, No 2 (2016) Supportive therapy for ovarian cancer
Abstract PDF
(Rus)
Pokataev I.A., Tyulyandin S.A.
Vol 15, No 1 (2013) Efficacy and safety of pemetrexed maintenance therapy in advanced non-small-cell lung cancer: a review of phase III studies
Abstract
Kit O.I., Vladimirova L.Y., Sholokhova E.A.
Vol 19, No 1 (2017) Anxiety and cognitive impairment in elderly patients with gastrointestinal cancers
Abstract PDF
(Rus)
Stilidi I.S., Kotyukova A.Y., Lyadov V.K.
Vol 18, No 1 (2016) Klinicheskie sluchai lecheniya gepatotsellyulyarnogo raka v Rossii. Klinicheskiy sluchay 1 Bolee chem 3-letnyaya stabilizatsiya protsessa gepatotsellyulyarnogo raka na fone dlitel'nogo priema preparata sorafenib
Abstract PDF
(Rus)
Sheko S.S., Dem'yanova G.A.
Vol 8, No 1 (2006) Fraksiparin kak osnovnoe sredstvo profilaktiki tromboembolii legochnoy arterii v posleoperatsionnom periode u bol'nykh kolorektal'nym rakom
Abstract
Makarov O.G.
Vol 16, No 3 (2014) Current algorhytm of screening and early diagnosis of hepatocellular carcinoma
Abstract
Tikhonov I.N., Pavlov C.S., Mayevskaya M.V., Ivashkin V.T.
Vol 18, No 2 (2016) Second primary cancer in patients with head and neck squamous cell carcinoma: case report
Abstract PDF
(Rus)
Agabekyan G.O., Stelmakh D.K., Aydarbekova A.A.
Vol 10, No 2 (2008) Primenenie tsetuksimaba v lechenii ploskokletochnogo raka golovy i shei
Abstract
Romanov I.S., Kupchan D.Z.
Vol 11, No 3 (2009) Targetnaya terapiya rasprostranennogo raka pochki: problema vybora preparata na primere mul'tikinaznykh ingibitorov
Abstract
Matveev V.B.
Vol 7, No 2 (2005) Estramustina fosfat (estratsit) v lechenii raka predstatel'noy zhelezy (po materialam Journal of Clinical Oncology, 2005 ASCO Proceedings)
Abstract
Podregul'skiy K.E.
Vol 20, No 3 (2018) Clinical prognostic factors of bilateral synchronous renal cancer
Abstract PDF
(Rus)
Komarov M.I., Matveev V.B., Volkova M.I., Komarov I.G., Ridin V.A.
Vol 19, No 3 (2017) Regorafenib: from clinical research to clinical practice
Abstract PDF
(Rus)
Fedyanin M.Y., Tryakin A.A.
Vol 8, No 1 (2006) Keliks (pegilirovannyy liposomal'nyy doksorubitsin) v programmnoy terapii 2-y linii metastaticheskogo raka molochnoy zhelezy
Abstract
Vol 20, No 2 (2018) The post-mastectomy syndrome: the secondary lympedema after the combined treatment of breast cancer (the literature review and own results)
Abstract PDF
(Rus)
Stepanova A.M., Merzlyakova A.M., Khulamhanova M.M., Trofimova O.P.
Vol 18, No 1 (2016) Systemic drug therapy of metastatic pancreatic cancer
Abstract PDF
(Rus)
Pokataev I.A., Tyulyandin S.A.
Vol 16, No 2 (2014) Successful treatment with sorafenib in patients with advanced hepatocellular carcinoma: clinical case
Abstract
Bisovskaya Y.V., Breder V.V., Medvedeva B.M., Gorbunova V.A.
Vol 15, No 4 (2013) The ways of erlotinib resistance overcoming in treatment of patients with eGFr mutated nsClC
Abstract
Orlov S.V.
Vol 11, No 3 (2009) Taktika vedeniya bol'nogo metastaticheskim kolorektal'nym rakom s izolirovannymi metastazami v pechen'
Abstract
Tryakin A.A.
Vol 9, No 3 (2007) Fulvestrant v sovremennoy terapii rasprostranennogo raka molochnoy zhelezy: farmakoekonomicheskoe obosnovanie
Abstract
Komarova V.P., Komarova L.E., Poddubnaya I.V.
Vol 8, No 2 (2006) Sovremennye vozmozhnosti lecheniya kolorektal'nogo raka
Abstract
Barsukov Y.A., Knysh V.I.
Vol 19, No 3 (2017) Dynamics of circulating tumor cells during neoadjuvant chemotherapy in patients with locally-advanced breast cancer
Abstract PDF
(Rus)
Nenakhova Y.N., Lyadov V.K., Poddubnaya I.V.
Vol 18, No 3 (2016) Modern therapy of radioactive iodine-refractory differentiated thyroid cancer: resolution of the Expert Council
Abstract PDF
(Rus)
Rumyantsev P.O., Gorbunova V.A., Podvyaznikov S.O., Zhukov N.V., Isaev P.A., Krylov V.V., Mudunov A.M., Rodichev A.A., Shavarova E.K.
Vol 17, No 4 (2015) Neoadjuvant systemic therapy of HER2-positive breast cancer
Abstract
Frolova M.A.
Vol 16, No 3 (2014) Experience of eribulin application in previously treated patients with metastatic or locally recurrent breast cancer under the clinical trial
Abstract
Ahmetzanov F.S., Ahmetzanova F.F.
Vol 15, No 2 (2013) Results of preoperative antitumor therapy in combination with bevacizumab and KRAS status during liver resections for colorectal cancer metastases
Abstract
Sekacheva M.I., Bagmet N.N., Polishchuk L.O., Glazova O.V., Zaklyazminskaya E.V., Skripenko O.G.
Vol 11, No 1 (2009) Problemy endokrinoterapii raka molochnoy zhelezy u muzhchin
Abstract
Borisova E.I., Voronina I.Y., Gutorov S.L.
Vol 9, No 1 (2007) Melkokletochnyy rak legkogo: chto izmenilos' za poslednie 30 let?
Abstract
Bychkov M.B.
Vol 7, No 3 (2005) Znachimost' khromoskopii, endosonografii i uvelichitel'noy endoskopii v reshenii diagnosticheskikh problem predopukholevoy patologii i rannego raka zheludochno-kishechnogo trakta
Abstract
Poddubnyy B.K., Kuvshinov Y.P., Malikhova O.A., Frolova I.P.
Vol 20, No 4 (2018) Non-small cell lung cancer with the tracheal bifurcation involvement. Carinal pneumonectomy or chemo-radiation therapy?
Abstract PDF
(Rus)
Dadyev I.A., Davydov M.M., Shogenov M.S., Abdullaev A.G., Ibraev M.A., Filatov A.A.
Vol 19, No 2 (2017) Brachytherapy with ultrasound assistance in patients with cervical cancer
Abstract PDF
(Rus)
Kizhaev Y.E., Razumova E.L., Bessolova O.V.
Vol 18, No 3 (2016) The results of epidemiological screening program of HER2 status in patients with breast cancer in the federal districts of the Russian Federation in 2015
Abstract PDF
(Rus)
Poddubnaya I.V., Frank G.A., Yagudina R.I., Koroleva N.I., Zavalishina L.E.
Vol 17, No 2 (2015) Liver transplantation for hepatocellular carcinoma
Abstract
Khubutiya M.S., Novruzbekov M.S., Olisov O.D., Galankina I.E., Zimina L.N.
Vol 16, No 2 (2014) Press-release. «Merck Serono» announces new retrospective analysis shows significant clinical benefit in overall survival for metastatic colorectal cancer patients with RAS wild-type tumors receiving Erbitux® plus FOLFIRI
Abstract
Vol 11, No 4 (2009) Tartseva (erlotinib) v terapii rasprostranennoy adenokartsinomy legkogo pri nalichii mutatsii retseptora epidermal'nogo faktora rosta
Abstract
Orlov S.V., Dvorakovskaya I.V., Mosin I.V., Stel'makh L.V., Gorokhov A.A., Martynenko O.N., Poltoratskiy A.N.
Vol 10, No 1 (2008) Predvaritel'nye rezul'taty induktsionnoy khimioterapii s paklitakselom pri mestnorasprostranennom rake sheyki matki
Abstract
Morkhov K.Y., Kuznetsov V.V., Lebedev A.I., Nechushkina V.M., Zakharova T.I., Tyulyandin S.A.
Vol 8, No 1 (2006) Opyt primeneniya Taksotera v kombinatsii s doksorubitsinom v kachestve khimioterapii 1-y linii u bol'nykh metastaticheskim rakom molochnoy zhelezy
Abstract
Samoylenko V.M., Gorbunova V.A., Koshelev M.N., Yurashko K.V.
Vol 7, No 1 (2005) Faktory prognoza pri rake molochnoy zhelezy
Abstract
Bozhok A.A., Semiglazov V.F., Semiglazov V.V., Arzumanov A.S., Kletsel' A.E.
Vol 20, No 2 (2018) The first results of the national programme for the diagnosis and treatment of HER2-positive breast cancer in Turkmenistan
Abstract PDF
(Rus)
Berdimyradova M.B., Khadjiev S.M., Khommadova D.N., Polatova G.O., Kakajanova A.O., Batyrov C.B., Penayev D.N., Agayeva B.G., Annaberdiyeva G.A.
Vol 19, No 1 (2017) The characteristics of determination of BRCA1 and BRCA2 mutations in serous ovarian cancer
Abstract PDF
(Rus)
Demidova I.A.
Vol 17, No 3 (2015) Efficacy of cisplatin-based combinations in chemoradiation therapy of cervical cancer
Abstract
Bazaeva I.Y., Gorbounova V.A., Kravets O.A., Khokhlova S.V., Romanova E.A.
Vol 16, No 4 (2014) Male breast cancer: review of the literature
Abstract
Nikolaev K.S., Semiglazov V.F., Semiglazov V.V.
Vol 15, No 3 (2013) Retseptor faktora rosta fibroblastov 1-go tipa kak mishen' tselenapravlennoy terapii pochechno-kletochnogo raka
Abstract
Timofeev I.V.
Vol 9, No 3 (2007) Postmastektomicheskaya limfedema verkhnikh konechnostey: vozmozhnosti konservativnogo lecheniya
Abstract
Myasnikova M.O.
Vol 8, No 2 (2006) Sostoyanie zabolevaemosti, smertnosti i onkologicheskoy pomoshchi pri zlokachestvennykh novoobrazovaniyakh kozhi v Navoiyskoy oblasti Respubliki Uzbekistan
Abstract
Kudryavtsev I.Y., Aksel' E.M., Kerimov R.A.
Vol 19, No 4 (2017) Soft tissue metastases of the gluteal region in HER2+ breast cancer: a clinical case
Abstract PDF
(Rus)
Kolyadina I.V., Ganshina I.P., Zhukova L.G., Abdullaev A.G., Andreeva Y.Y., Danzanova T.Y., Sinyukova G.T., Komov D.V., Kozlov N.A., Filonenko D.A., Gordeeva O.O., Lubennikova E.V.
Vol 18, No 2 (2016) Predictive biomarkers in chemotherapy of pancreatic duct adenocarcinoma: rewiew of the literature
Abstract PDF
(Rus)
Kovalenko Z.A., Kekeeva T.V., Lyadov V.K.
Vol 17, No 4 (2015) Modern possibilities of targeted therapy in metastatic colorectal cancer
Abstract
Gorbunova V.A.
Vol 15, No 3 (2013) Prolongirovannaya blokada angiogeneza pri metastaticheskom kolorektal'nom rake (novye dannye)
Abstract
Artamonova E.V.
Vol 11, No 1 (2009) Rol' i mesto tsetuksimaba v 1-y linii terapii metastaticheskogo kolorektal'nogo raka
Abstract
Kopp M.V., Koroleva I.A.
Vol 9, No 1 (2007) Antiestrogennaya terapiya pri rake molochnoy zhelezy. Naskol'ko bezopasny ingibitory aromatazy?
Abstract
Ptushkin V.V.
Vol 7, No 2 (2005) Farmorubitsin v klinicheskoy praktike
Abstract
Gorbunova V.A.
Vol 20, No 3 (2018) Vliyanie na prognoz estrogenovykh retseptorov a v opukholevykh kletkakh u patsientov, radikal'no operirovannykh po povodu nemelkokletochnogo raka legkogo
Abstract PDF
(Rus)
Novikov D.V., Polotskiy B.E., Bogush T.A., Davidov M.M., Ahmedov B.B., Rotobelskaya L.E.
Vol 19, No 3 (2017) Olaparib maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer
Abstract PDF
(Rus)
Khokhlova S.V.
Vol 18, No 2 (2016) Development of cytotoxic chemotherapy in metastatic breast cancer with a triple-negative phenotype
Abstract PDF
(Rus)
Karabina E.V., Zhukova L.G.
Vol 16, No 1 (2014) The role of tamoxifen in the therapy of metastatic ovarian cancer
Abstract
Davidenko I.S., Kazantseva M.V., Porhanova N.V., Ohanyan M.R.
Vol 11, No 4 (2009) Aromazin v ad\"yuvantnoy terapii raka molochnoy zhelezy
Abstract
Artamonova E.V.
Vol 9, No 4 (2007) Molekulyarno-biologicheskie markery v khimioterapevticheskom lechenii metastaticheskogo kolorektal'nogo raka
Abstract
Kuznetsova E.A., Eropkin P.V., Kashnikov V.N.
Vol 8, No 3 (2006) Faktory prognoza v opredelenii ob\"ema operatsii pri differentsirovannom rake shchitovidnoy zhelezy
Abstract
Brzhezovskiy V.Z., Lyubaev V.L., Kochurina G.Y., Subramanian S.
Vol 5, No 2 (2003) Sovremennye standarty lecheniya raka yaichnikov
Abstract
Kharitonova T.V.
Vol 20, No 2 (2018) Ribociclib in 1st line HR+ breast cancer treatment
Abstract PDF
(Rus)
Zhukova L.G., Ganshina I.P., Gordeeva O.O., Lubennikova E.V.
Vol 19, No 1 (2017) Predictive factors of achievement pathological complete response at neoadjuvant chemotherapy of primary operable breast cancer
Abstract PDF
(Rus)
Pavlikova O.A., Kolyadina I.V., Komov D.V., Vishnevskaya Y.V., Poddubnaya I.V.
Vol 17, No 3 (2015) Latent herpes virus infection in the carcinogenesis of bladder cancer
Abstract
Loran O.B., Sinyakova L.A., Gundorova L.V., Kosov V.A., Kosova I.V., Kolbasov D.N., Kononkov I.V.
Vol 16, No 2 (2014) Pharmacoeconomic usefulness of the drug Giotrif® (afatinib) in first-line treatment of locally advanced or metastatic non-small cell lung cancer with a mutation of epidermal growth factor receptor (EGFR)
Abstract
Kolbin A.S., Kurylev A.A., Pavlysh A.V., Proskurin M.A., Balykina Y.Y.
Vol 15, No 4 (2013) The efficiency of trabectedin in the monotherapy and combinations in the treatment of advanced ovarian cancer
Abstract
Cherkasova M.V., Khokhlova S.V., Limareva S.V., Bazaeva I.Y., Orel N.F., Gorbunova V.A., Poddubnaya I.V.
Vol 9, No 2 (2007) Sravnitel'noe issledovanie opredeleniya NER2-statusa raka molochnoy zhelezy metodami immunogistokhimii i in situ gibridizatsii
Abstract
Zavalishina L.E., Andreeva Y.Y., Ryazantseva A.A., Bateva M.V., Frank G.A.
Vol 7, No 3 (2005) Sovremennye vozmozhnosti lekarstvennoy terapii operabel'nogo raka molochnoy zhelezy (po materialam St. Gallen, 2005)
Abstract
Letyagin V.P., Vysotskaya I.V.
Vol 21, No 1 (2019) Opportunities of the pharmacogenetic approach to personalized tamoxifen breast cancer therapy: case reports
Abstract PDF
(Rus)
Savelyeva M.I., Dudina I.A., Zaharenkova J.S., Ignatova A.K., Ryzhikova K.A., Sozaeva Z.A., Kudlay D.A., Perfileva O.M., Poddubnaya I.V.
Vol 19, No 3 (2017) Irreversible electroporation of locally advanced unresectable pancreatic cancer
Abstract PDF
(Rus)
Patyutko Y.I., Polyakov A.N., Kudashkin N.E., Podluzhnyi D.V., Chistyakova O.V.
Vol 18, No 2 (2016) Long-term treatment of neuroendocrine tumor of the pancreas
Abstract PDF
(Rus)
Khvastunov R.A., Egorov S.V., Kargin A.V., Kim A.Y.
Vol 17, No 2 (2015) Efficacy and safety of extimia® (empegfilgrastim): results of a double-blind controlled phase iii study in patients with diagnosis «breast cancer» receiving myelosuppressive chemotherapy
Abstract
Krivorotko P.V., Burdaeva O.N., Nechaeva M.N., Frolova M.A., Kopp M.V., Abrosimova A.A., Ivanov R.A.
Vol 16, No 2 (2014) Algorithm of treatment of patients with castrate-resistant prostate cancer: modern concept and perspectives
Abstract
Alekseev B.Y., Nyushko K.M., Kalpinskiy A.S., Kaprin A.D.
Vol 15, No 2 (2013) The concept of resectability in the treatment of colorectal cancer liver metastases: the present notion
Abstract
Bagmet N.N., Bedzhanyan A.L., Polishchuk L.O., Sekacheva M.I., Shatveryan G.A., Skipenko O.G.
Vol 11, No 1 (2009) Bevatsizumab (Avastin) v kombinatsii s taksanami v 1-y linii lecheniya HER-2-negativnogo metastaticheskogo raka molochnoy zhelezy(Rezul'taty issledovaniya AVADO)
Abstract
Zhukova L.G.
Vol 9, No 1 (2007) Immunogistokhimicheskoe opredelenie ekspressii HER2/neu pri rake molochnoy zhelezy (po dannym Smolenskogo oblastnogo onkologicheskogo klinicheskogo dispansera)
Abstract
Shisterova O.A., Golik E.P.
Vol 7, No 2 (2005) Aromazin (ekzemestan) v neoad\"yuvantnoy i ad\"yuvantnoy gormonoterapii raka molochnoy zhelezy
Abstract
Makarenko N.P.
Vol 20, No 4 (2018) A method of laparoscopic installation of port systems for intra-abdominal chemotherapy in patients with advanced ovarian cancer
Abstract PDF
(Rus)
Lozovaya V.V., Cherkes L.V., Malikhova O.A., Poddubny B.K.
Vol 19, No 2 (2017) Perspectives of pharmacogenetics approach to personalized tamoxifen therapy
Abstract PDF
(Rus)
Savelyeva M.I., Ignatova A.K., Panchenko Y.S., Urvantseva I.A., Poddubnaya I.V.
Vol 18, No 2 (2016) New opportunities to improve of duration and quality of life: eribulin in the treatment of patients with advanced breast cancer
Abstract PDF
(Rus)
Semiglazova T.Y., Klyuge V.A., Semiglazov V.V., Teletaeva G.M., Krivorotko P.V., Dashyan G.A., Paltuev R.M., Tkachenko E.V., Donskikh R.V., Semiglazov V.F.
Vol 16, No 3 (2014) Clinical experience with abiraterone acetate application in patients with castration-resistant prostate cancer
Abstract
Gridneva Y.V., Matveev V.B., Kupchan D.Z., Kalinin S.A., Peters M.V.
1 - 100 of 280 Items 1 2 3 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies